DIM BioConvS
Created in 2022
- BETA
To investigate (B)
Some signals may appear as inconsistent with a regular activity Social networks
865Activities
Entity types
Location
5 Rue Thomas Mann, 75013 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 1
Engaged corporates
7
1 3Added in Motherbase
1 year, 1 month ago
healthtech Value proposition
[Automatic translation follows] "Major Interest Area" project of the Ile-de-France Region, led by the University of Paris Cité
BioConvergence for Health (BioConvS) is a "Major Interest Area" (MIA) initiative of the Ile-de-France Region that aims to structure the communities of synthetic biology, biotherapy and bioproduction, to support the transition from scientific excellence to innovation, and to position the Ile-de-France region as an international reference in the field.
BioConvS is led by Université Paris Cité in partnership with Sorbonne Université, Institut Curie - PSL, Institut Micalis (INRAe, AgroParisTech, Université de Saclay), INSERM, Généthon, Génopole and others. BioConvS brings together stakeholders from the public and private sectors and benefits from €12.5 million in support from the Ile de France Region.
Coordinators: Amanda Silva Brun, Ariel Lindner
Project manager: Chiara Fracassi
Innovation Officer: Carole Oudot
synthetic biology, bioproduction, biotherapy, innovation, technology transfer, entrepreneurship, training, and networkingOriginal language
Projet "Domaine d'Intérêt Majeur" de la Région Ile-de-France, porté par l'Université Paris Cité
BioConvergence pour la Santé (BioConvS) est une initiative "Domaine d'Intérêt Majeur" (DIM) de la Région Ile-de-France qui vise à structurer les communautés de la biologie synthétique, de la biothérapie et de la bioproduction, pour accompagner la transition de l'excellence scientifique vers l'innovation , et positionner la région Île-de-France comme une référence internationale dans le domaine.
BioConvS est piloté par Université Paris Cité en partenariat avec Sorbonne Université, Institut Curie - PSL, Institut Micalis (INRAe, AgroParisTech, Université de Saclay), INSERM, Généthon, Génopole et autres. BioConvS regroupe des acteurs des secteurs public et privé et bénéficie d'un soutien de 12,5M€ de la Région Ile de France.
Coordinators: Amanda Silva Brun, Ariel Lindner
Project manager: Chiara Fracassi
Innovation Officer: Carole Oudot
synthetic biology, bioproduction, biotherapy, innovation, technology transfer, entrepreneurship, training, and networking
Bioconvs |
https://bioconvs.org/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Gouvernement | Other 9 Oct 2024 | | |
 | Ministère de la Santé | Other 9 Oct 2024 | | |
 Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Ministère de l'Enseignement supérieur et de la Recherche Government Administration | Other 9 Oct 2024 | | |
 CEA Research | CEA Research | Other 9 Oct 2024 | | |
 Genopole Biotechnology, Biotechnology Research | Genopole Biotechnology, Biotechnology Research | Other 5 Dec 2024 | | |
 Région Ile de France National and local authorities, Government Administration | Région Ile de France National and local authorities, Government Administration | Other 20 Jan 2025 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 5 Jul 2024 | | |